Skip to content

Glucose lowering effect Of walking breaks in pregnancy study

Understanding the effect of breaking up sitting on postprandial blood glucose in women at risk of gestational diabetes mellitus

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12616000945426
Acronym
GLOW (Glucose Lowering effect Of Walking breaks) in pregnancy study
Enrollment
25
Registered
2016-07-18
Start date
2016-07-25
Completion date
2018-04-13
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The prevalence of gestational diabetes mellitus (GDM) is increasing worldwide, with current Australian prevalence rates estimated to be between 13-16%. The primary goal of GDM management is to prevent hyperglycaemia, as there is a clear dose-dependent relationship between increased plasma glucose levels during pregnancy and adverse outcomes for both the mother and child. Compliance rates for exercise intervention trials in pregnant women are generally poor (reporting adherence as low as 16-55%). Furthermore, the majority of pregnant women do not reach the recommended levels of physical activity; and overall physical activity levels tend to decrease throughout pregnancy (particularly in caregiving, outdoor, household and recreational activities). The lack of adherence to an exercise regime could be due to feelings of tiredness and increasing immobility as pregnancy progresses, which would limit the ability or motivation for women to maintain exercise efforts for more than 10 min at a time, particularly for women who are not normally active. In light of the fact that brief (2-3 minutes), regular (every 20-30 minutes), light ambulatory activities have been demonstrated to be effective in improving postprandial glucose control in overweight/obese and T2D patients, consideration of the “breaks in sitting” approach may be appropriate for women at risk for or diagnosed with GDM. Given that post-challenge glucose is considered a surrogate for postprandial glycaemia, there is value in examining the effect of breaking up sitting in the context of routine screening for GDM. Based on past studies done within our laboratory, we anticipate that breaking up sitting will lower postprandial glucose responses compared to prolonged sitting without breaks, and may even prevent levels from entering the GDM range. The results of this trial will help inform the design and development of a larger, chronic study looking at breaking up sitting to improve pregnancy outcomes for mothers and offspring. Hypothesis: We hypothesise that regular, light intensity ambulatory breaks in sitting (2 minutes every 20 minutes) will lower post-OGTT glucose and insulin responses in women at risk for developing GDM, compared to sitting-only control. Study Design: A cross-over trial, involving women at risk of GDM, of two laboratory-based interventions undertaken during a standard 75g oral glucose tolerance test. Outcomes: Primary outcomes – postprandial glycaemic response calculated as the incremental area under the curve (iAUC) from half hourly blood sampling over a 4 hour period. Secondary outcomes – postprandial insulin response calculated as iAUC and mean blood pressure.

Interventions

In this cross-over trial, participants will complete two laboratory-based conditions, separated by a 7 day wash out. The experimental condition involves 4.5 hours of prolonged sitting with intermittent bouts of gentle walking. Participants will remain seated for the initial 30 minutes (steady state period, after which they will consume a 75g glucose load and will complete a 2 minute bout of gentle walking every 20 minutes for the remaining 4 hours (total duration of walking = 12 x 2 minute bouts

In this cross-over trial, participants will complete two laboratory-based conditions, separated by a 7 day wash out. The experimental condition involves 4.5 hours of prolonged sitting with intermittent bouts of gentle walking. Participants will remain seated for the initial 30 minutes (steady state period, after which they will consume a 75g glucose load and will complete a 2 minute bout of gentle walking every 20 minutes for the remaining 4 hours (total duration of walking = 12 x 2 minute bouts = 24 minutes). All activities will take place in a controlled laboratory environmental under the supervision of trained clinical research staff. During the condition, participants will be permitted to watch television, DVDs or read.

Sponsors

Professor David Dunstan
Lead SponsorIndividual

Study design

Allocation
Non-randomised trial
Intervention model
Crossover
Primary purpose
Prevention
Masking
Blinded (masking used) (Investigator)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Eligibility includes women 24-28 weeks gestation and at increased risk for developing gestational diabetes mellitus identified by a validated risk prediction tool (Monash GDM score greater than 4).

Exclusion criteria

Exclusion will be based on: less than 18 years of age, multiple pregnancy, diagnosed type 1 or 2 diabetes, a BMI greater than 45 kg/m^2, pre-existing chronic medical conditions, absolute contraindications to aerobic exercise during pregnancy according to the American College of Obstetricians and Gynecologists (ACOG) guidelines, currently sitting for less than 5 hours per day, regularly engaged in moderate-intensity exercise more than 150 min/week for more than 3 months, current smoker or use of nicotine replacement therapy, and non-English speaking.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026